Neuroendocrine markers in adenocarcinomas: An investigation of 356 cases

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 858-861

  Yao, Gen You ^a   Zhou, Ji Lin ^a   Lai, Mao De ^a   Chen, Xiao Qing ^a   Chen, Pei Hui ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CHROMOGRANIN; CORTICOTROPIN; GASTRIN; GLUCAGON; HORMONE; POLYPEPTIDE; SEROTONIN; SOMATOSTATIN;

ADENOCARCINOMA; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; GASTROINTESTINAL CARCINOMA; HOSPITAL; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LARGE INTESTINE; MAJOR CLINICAL STUDY; NEUROSECRETORY CELL; PANCREAS CANCER; PATHOLOGY; PROGNOSIS; PROSTATE CANCER; STATISTICAL ANALYSIS; STOMACH CANCER; SURVIVAL RATE; TISSUE SECTION; TUMOR DIFFERENTIATION;

EID: 0038638911     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.858     Document Type: Article

References (32)

1. Papotti M, Macri L, Finzi G, Capella C, Eusebi V, Bussolati G. Neuroendocrine differentiation in carcinomas of the breast: A study of 51 cases. Semin Diagn Pathol 1989; 6: 174-188
2. Van Laarhoven HA, Gratama S, Wereldsma JC. Neuroendocrine carcinoid tumours of the breast: A variant of carcinoma with neuroendocrine differentiation. J Surg Oncol 1991; 46: 125-132
3. Giovanella L, Marelli M, Ceriani L, Giardina G, Garancini S, Colombo L. Evaluation of chromogranin A expression in serum and tissues of breast cancer patients. Int J Biol Markers 2001; 16: 268-272
4. Kimura N, Sasano N, Yamada R, Satoh J. Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour. Virchows Arch A Pathol Anat Histopathol 1988; 413: 33-38
5. Kimura N, Hoshi S, Takahashi M, Takeha S, Shizawa S, Nagura H. Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumors. J Urol 1997; 157: 565-568
6. Portel-Gomes GM, Grimelius L, Johansson H, Wilander E, Stridsberg M. Chromogranin A in human neuroendocrine tumors: An immunohistochemical study with region-specific antibodies. Am J Surg Pathol 2001; 25: 1261-1267
7. Bernini GP, Moretti A, Ferdeghini M, Ricci S, Letizia C, D'Erasmo E, Argenio GF, Salvetti A. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours. Br J Cancer 2001; 84: 636-642
8. Yao GY, Chen PH, Lai MD, Hong LY. Study of 9 neuroendocrine markers in pancreatic tumors. Zhengjiang Yike Daxue Xuebao 1995; 24: 56-58
9. Chen FX, Corti A, Siccardi AG. DIBIT; San Raffaele H. Characterization of antigenic sites of Human Chromogranin A. Shanghai Mian Yixue Zazhi 1998; 18: 215-219
10. Di Sant'Agnese PA. Neuroendocrine differentiation in prostatic carcinoma: An update. Prostate Suppl 1998; 8: 74-79
11. Chen BF, Yin H. Neuro-endocrine type of gastric carcinoma. Immunohistochemical and electron microscopic studies of 100 cases. Chin Med J 1990; 103: 561-564
12. Yu JY, Wang LP, Meng YH, Hu M, Wang JL, Bordi C. Classification of gastric neuroendocrine tumors and its clinicopathologic significance. World J Gastroenterol 1998; 4: 158-161
13. Chabot V, De Keyzer Y, Gebhard S, Uske A, Bischof-Delaloye A, Rey F, Dusmet M, Gomez F. Ectopic ACTH Cushing's syndrome: V3 vasopressin receptor but not CTH receptor gene Expression in a pulmonary carcinoid tumor. Horm Res 1998; 50: 226-231
14. Mao C, El Attar A, Domenico DR, Kim K, Howard JM. Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature. Int J Pancreatol 1998; 23: 153-164
15. Duchesne G, Cassoni A, Pera M. Radiosensitivity related to neuroendocrine and endodermmal differentiation in lung carcinoma lines. Radiother Oncol 1988; 13: 153-161
16. Tezel E, Nagasaka T, Nomoto S, Sugimoto H, Nakao A. Neuroendocrine-like differentiation in patients with pancreatic carcinoma. Cancer 2000; 89: 2230-2236
17. Yao G, Zhou J, Zhao Z. Studies on the DNA content of breast carcinoma cells with neuroendocrine differentiation. Chin Med J 2002; 115: 296-298
18. Maluf HM, Zukerberg LR, Dickersin GR, Koerner FC. Spindle-cell argyrophilic mucin-producing carcinoma of the breast. Histological, ultrastructural, and immunohistochemical studies of two cases. Am J Surg Pathol 1991; 15: 677-686
19. Scopsi L, Andreola S, Pilotti S, Testori A, Baldini MT, Leoni F, Lombardi L, Hutton JC, Shimizu F, Rosa P. Argyrophilia and granin (chromogranin/secretogranin) expression in Female breast carcinomas. Their relationship to survival and other disease parameters. Am J Surg Pathol 1992; 16: 561-576
20. Grabowski P, Schindler I, Anagnostopoulos I, Foss HD, Riecken EO, Mansmann U, Stein H, Berger G, Buhr HJ, Scherubl H. Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. Eur J Gastroenterol Hepatol 2001; 13: 405-411
21. Sapino A, Papotti M, Righi L, Cassoni P, Chiusa L, Bussolati G. Clinical significance of neuroendocrine carcinoma of the breast. Ann Oncol 2001; 12(Suppl 2): S115-117
22. Matsui T, Kataoka M, Sugita Y, Itoh T, Ichihara T, Horisawa M, Koide A, Ichihara T, Horisawa M, Koide A, Ichihara S, Nakao A. A case of small cell carcinoma of the stomach. Hepatogastroenterology 1997; 44: 156-160
23. Yang GC, Rotterdam H. Mixed (composite) glandular-endocrine cell carcinoma of the stomach. Report of a case and review of literature. Am J Surg Pathol 1991; 15: 592-598
24. Upp JR Jr, Olson D, Poston GJ, Alexander RW, Townsend CM Jr, Thompson JC. Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995. Am J Surg 1988; 155: 29-35
25. Anderson JV, Bloom SR. Neuroendocrine tumours of the gut: Long-term therapy with the somatostatin analogue SMS 201-995. Scand J Gastroenterol Suppl 1986; 119: 115-128
26. Oda Y, Tanaka Y, Naruse T, Sasanabe R, Tsubamoto M, Funahashi H. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors. Surg Today 2002; 32: 690-694
27. O'Byrne KJ, Carney DN. Somatostatin and the lung. Lung Cancer 1993; 10: 151-172
28. Taylor JE, Moreau JP, Baptiste L, Moody TW. Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells. Peptides 1991; 12: 839-843
29. Taylor JE, Bogden AE, Moreau JP, Coy DH. In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue. Biochem Biophys Res Commun 1988; 153: 81-86
30. Diaz-Sanchez CL, Molano Romero RA, Martinez Gonzalez M, Marquez Rivera ML, Halabe-Cherem J. Gastric neuroendocrine tumor. Rev Gastroenterol Mex 1998; 63: 97-100
31. Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol 2001; 12(Suppl 2): S95-99
32. Eriksson B, Oberg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion 2000; 621: 33-38